VXRT - vaxart.com Debt to Book Capitalization Ratio
Historical debt-to-book capitalization dynamics on GURU.Markets demonstrate the financial stability of Vaxart, Inc. (VXRT), where the value 0.00 describes the current level. Risks are linked to liquidity shortages and dependence on US government subsidies. The brand is valued for its innovative oral vaccines that simplify immunization. Meanwhile, Vaxart, Inc. (VXRT) is optimizing costs by outsourcing production and testing to external contractors.
%20Debt%20to%20Net%20Assets%20Ratio&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_VXRT_-_Vaxart-Inc._-_Debt-to-Net-Assets-Ratio "Vaxart Inc. - VXRT Debt to Book Capitalization Ratio (period 07/04/2022 - 07/19/2025) | 👁️GURU.Markets👁️")
Summary analytical data breakdowns for vaxart.com (VXRT)
Investors must assess the resilience of Vaxart, Inc. (VXRT) within the capital-intensive biotechnology sector. This ratio measures the proportion of borrowed funds relative to equity, determining the level of financial leverage. Analyzing the debt-to-book capitalization ratio helps identify overvaluation of the debt load. Minimizing this metric confirms the funding reliability for the sustainable development of oral vaccines. Reducing debt dependency ensures stable growth without the risk of default.